{"id":"https://openalex.org/W2783596779","doi":"https://doi.org/10.1158/1078-0432.ccr-17-2796","title":"IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors","display_name":"IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors","publication_year":2018,"publication_date":"2018-01-16","ids":{"openalex":"https://openalex.org/W2783596779","doi":"https://doi.org/10.1158/1078-0432.ccr-17-2796","mag":"2783596779","pmid":"https://pubmed.ncbi.nlm.nih.gov/29339439","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5884732"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-17-2796","doi":"https://doi.org/10.1158/1078-0432.ccr-17-2796","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-17-2796","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5884732","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090717354","display_name":"Remco Jurriaan Molenaar","orcid":"https://orcid.org/0000-0001-5651-3997","observed_orcids":["https://orcid.org/0000-0001-5651-3997"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL","US"],"is_corresponding":false,"raw_author_name":"Remco J. Molenaar","raw_affiliation_strings":["1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","2Department of Medical Biology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","3Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"2Department of Medical Biology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"3Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4387152927","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063314967","display_name":"Tomas Radivoyevitch","orcid":"https://orcid.org/0000-0002-9701-1851","observed_orcids":["https://orcid.org/0000-0002-9701-1851"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tomas Radivoyevitch","raw_affiliation_strings":["5Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015705148","display_name":"Yasunobu Nagata","orcid":"https://orcid.org/0000-0002-0866-929X","observed_orcids":["https://orcid.org/0000-0002-0866-929X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasunobu Nagata","raw_affiliation_strings":["1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033165278","display_name":"Mohammed Khurshed","orcid":"https://orcid.org/0000-0002-1611-1798","observed_orcids":["https://orcid.org/0000-0002-1611-1798"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Mohammed Khurshed","raw_affiliation_strings":["2Department of Medical Biology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medical Biology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4387152927","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905061","display_name":"Bartolomiej Przychodzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bartolomiej Przychodzen","raw_affiliation_strings":["1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050620740","display_name":"Hideki Makishima","orcid":"https://orcid.org/0000-0001-5983-8578","observed_orcids":["https://orcid.org/0000-0001-5983-8578"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hideki Makishima","raw_affiliation_strings":["1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033704013","display_name":"Mingjiang Xu","orcid":"https://orcid.org/0000-0002-7063-6253","observed_orcids":["https://orcid.org/0000-0002-7063-6253"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mingjiang Xu","raw_affiliation_strings":["6Sylvester Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Sylvester Comprehensive Cancer Center, Department of Biochemistry and Molecular Biology, University of Miami, Miami, Florida","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070456575","display_name":"Fonnet E. Bleeker","orcid":"https://orcid.org/0000-0002-9337-6909","observed_orcids":["https://orcid.org/0000-0002-9337-6909"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Fonnet E. Bleeker","raw_affiliation_strings":["7Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","8Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"8Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110360711","display_name":"Johanna W. Wilmink","orcid":"https://orcid.org/0000-0002-1677-1278","observed_orcids":["https://orcid.org/0000-0002-1677-1278","https://orcid.org/0000-0001-6686-2904"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Johanna W. Wilmink","raw_affiliation_strings":["3Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4387152927","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016810759","display_name":"Hetty E. Carraway","orcid":"https://orcid.org/0000-0001-5241-3614","observed_orcids":["https://orcid.org/0000-0001-5241-3614"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hetty E. Carraway","raw_affiliation_strings":["9Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102826236","display_name":"Sudipto Mukherjee","orcid":"https://orcid.org/0000-0002-8325-2603","observed_orcids":["https://orcid.org/0000-0002-8325-2603","https://orcid.org/0009-0002-0717-6319"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudipto Mukherjee","raw_affiliation_strings":["9Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","9Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"9Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085918635","display_name":"Cornelis J.F. Van Noorden","orcid":"https://orcid.org/0000-0002-6191-0505","observed_orcids":["https://orcid.org/0000-0002-6191-0505"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4387152927","display_name":"Cancer Center Amsterdam","ror":"https://ror.org/0286p1c86","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4387152927"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Cornelis J.F. van Noorden","raw_affiliation_strings":["2Department of Medical Biology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medical Biology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"4Cancer Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4387152927","https://openalex.org/I887064364"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085974329","display_name":"Jaroslaw Pawel Maciejewski","orcid":"https://orcid.org/0000-0002-6837-4346","observed_orcids":["https://orcid.org/0000-0002-6837-4346"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jaroslaw P. Maciejewski","raw_affiliation_strings":["1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5085974329"],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":null,"apc_paid":null,"fwci":9.0007,"has_fulltext":false,"cited_by_count":110,"citation_normalized_percentile":{"value":0.98447929,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"24","issue":"7","first_page":"1705","last_page":"1715"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9125999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.07289999723434448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.9340000152587891},{"id":"https://openalex.org/keywords/idh2-mutation","display_name":"IDH2 mutation","score":1.0},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":0.9459999799728394},{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9549999833106995},{"id":"https://openalex.org/keywords/d-2-hydroxyglutarate","display_name":"D-2-hydroxyglutarate","score":0.9070000052452087},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.7950000166893005},{"id":"https://openalex.org/keywords/atm","display_name":"ATM","score":0.6430000066757202},{"id":"https://openalex.org/keywords/idh1-2-inhibitors","display_name":"IDH1/2 inhibitors","score":0.7279999852180481},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7149999737739563},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.7680000066757202},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.8799505829811096},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7340704202651978},{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.6419126987457275},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6162030696868896},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.47059357166290283},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4672795534133911},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.42214447259902954},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34249013662338257},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33273398876190186},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2480173110961914},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.21965545415878296},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.11239582300186157},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08529108762741089},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.05603626370429993}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007521","descriptor_name":"Isocitrate Dehydrogenase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045325","descriptor_name":"HCT116 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1158/1078-0432.ccr-17-2796","doi":"https://doi.org/10.1158/1078-0432.ccr-17-2796","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-17-2796","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:29339439","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29339439","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:5421431","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5884732","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5884732","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5884732","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/e2d54147-91e1-4bc7-b50f-9583b0284bf0","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/idh12-mutations-sensitize-acute-myeloid-leukemia-to-parp-inhibition-and-this-is-reversed-by-idh12mutant-inhibitors(e2d54147-91e1-4bc7-b50f-9583b0284bf0).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical cancer research, 1705 - 1715. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/c8c41495-fa91-40a5-a287-b60a2817e081","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/c8c41495-fa91-40a5-a287-b60a2817e081","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molenaar, R J, Radivoyevitch, T, Nagata, Y, Khurshed, M, Przychodzen, B, Makishima, H, Xu, M, Bleeker, F E, Wilmink, J W, Carraway, H, Mukherjee, S, Sekeres, M A, van Noorden, C J F & Maciejewski, J P 2018, 'IDH1/2 mutations sensitize acute myeloid leukemia to PARP inhibition and this is reversed by IDH1/2-mutant inhibitors', Clinical cancer research, pp. 1705-1715. https://doi.org/10.1158/1078-0432.CCR-17-2796","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5421431","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5884732","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1101681540","display_name":"Roles of TET2-dependent DNA demethylation intermediates in hematological malignancies","funder_award_id":"R01HL145883","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G2246609074","display_name":"Investigations of Consequences of U2AF1 Mutations in MDS","funder_award_id":"R01HL118281","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G2902946885","display_name":null,"funder_award_id":"UVA 2014\u20106839","funder_id":"https://openalex.org/F4320322777","funder_display_name":"KWF Kankerbestrijding"},{"id":"https://openalex.org/G424740486","display_name":null,"funder_award_id":"AMC2016.1-10460","funder_id":"https://openalex.org/F4320322777","funder_display_name":"KWF Kankerbestrijding"},{"id":"https://openalex.org/G4952529857","display_name":"Therapeutic Implications of Molecular Defects in Bone Marrow Failure","funder_award_id":"R35HL135795","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5633078210","display_name":"Novel Spliceosomal Defects in Myelodysplastic Syndromes","funder_award_id":"R01HL132071","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5663319766","display_name":"Molecular pathogenesis in myelodysplastic syndromes (MDS).","funder_award_id":"26221308","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G6096555511","display_name":"RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target","funder_award_id":"R01HL123904","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320307177","display_name":"Aplastic Anemia and MDS International Foundation","ror":"https://ror.org/05s1w1241"},{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W1553367038","https://openalex.org/W1812010256","https://openalex.org/W1964977164","https://openalex.org/W1970758655","https://openalex.org/W1988756388","https://openalex.org/W2026134786","https://openalex.org/W2036504531","https://openalex.org/W2036862498","https://openalex.org/W2040239825","https://openalex.org/W2047867594","https://openalex.org/W2051207198","https://openalex.org/W2061452747","https://openalex.org/W2071457560","https://openalex.org/W2075017638","https://openalex.org/W2080212479","https://openalex.org/W2080452140","https://openalex.org/W2081576971","https://openalex.org/W2087360892","https://openalex.org/W2094851085","https://openalex.org/W2103192145","https://openalex.org/W2103272465","https://openalex.org/W2107816126","https://openalex.org/W2114843025","https://openalex.org/W2123299008","https://openalex.org/W2125370645","https://openalex.org/W2126817554","https://openalex.org/W2131860315","https://openalex.org/W2132834292","https://openalex.org/W2141324982","https://openalex.org/W2149441684","https://openalex.org/W2154313451","https://openalex.org/W2155106329","https://openalex.org/W2155800445","https://openalex.org/W2162619595","https://openalex.org/W2164277652","https://openalex.org/W2171074831","https://openalex.org/W2195565943","https://openalex.org/W2209736027","https://openalex.org/W2235405584","https://openalex.org/W2461331156","https://openalex.org/W2548311344","https://openalex.org/W2561161989","https://openalex.org/W2585230893","https://openalex.org/W2587235534","https://openalex.org/W2588147230","https://openalex.org/W2592164001","https://openalex.org/W2592842961","https://openalex.org/W2597695339","https://openalex.org/W2606667746","https://openalex.org/W2608857438","https://openalex.org/W2621721411","https://openalex.org/W2623089849","https://openalex.org/W2624245118","https://openalex.org/W2746871805","https://openalex.org/W2793046629","https://openalex.org/W2804400342","https://openalex.org/W6660246229","https://openalex.org/W6749281400"],"related_works":["https://openalex.org/W3171611919","https://openalex.org/W2984449647","https://openalex.org/W4220670314","https://openalex.org/W4237855843","https://openalex.org/W3175549020","https://openalex.org/W3162010243","https://openalex.org/W2810665266","https://openalex.org/W4200406834","https://openalex.org/W3163447184","https://openalex.org/W4205246208"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Somatic":[2],"mutations":[3],"in":[4,7,39,96,158,198,204,215,219],"IDH1/2":[5],"occur":[6],"approximately":[8],"20%":[9],"of":[10,120,131,139,141,186,195,206,209],"patients":[11],"with":[12,27,107,176,217],"myeloid":[13,17],"neoplasms,":[14],"including":[15],"acute":[16],"leukemia":[18],"(AML).":[19],"IDH1/2MUT":[20,49,79,99,121,132,159,162,187,199,220],"enzymes":[21],"produce":[22],"D-2-hydroxyglutarate":[23],"(D2HG),":[24],"which":[25],"associates":[26],"increased":[28,81],"DNA":[29,67,82,143],"damage":[30,68,83,144],"and":[31,36,60,69,75,84,89,94,111,148],"improved":[32],"responses":[33,70,153],"to":[34,71,86,155,167],"chemo/radiotherapy":[35],"PARP":[37,76,91,109,168,210],"inhibitors":[38,92,100,169,188,211],"solid":[40],"tumor":[41],"cells.":[42,98,123,160],"Whether":[43],"this":[44],"also":[45],"holds":[46],"true":[47],"for":[48,66],"AML":[50,62,97,122,163],"is":[51],"not":[52,149,214],"known.":[53],"Experimental":[54],"Design:":[55],"Well-characterized":[56],"primary":[57],"IDH1MUT,":[58],"IDH2MUT,":[59],"IDH1/2WT":[61],"cells":[63,133,164],"were":[64],"analyzed":[65],"daunorubicin,":[72,87,182],"ionizing":[73],"radiation,":[74],"inhibitors.":[77],"Results:":[78],"caused":[80,135],"sensitization":[85],"irradiation,":[88],"the":[90,118,128,142,193],"olaparib":[93],"talazoparib":[95],"protected":[101],"against":[102],"these":[103],"treatments.":[104],"Combined":[105],"treatment":[106],"a":[108,177],"inhibitor":[110],"daunorubicin":[112,218],"had":[113],"an":[114],"additive":[115],"effect":[116],"on":[117],"killing":[119],"We":[124],"provide":[125],"evidence":[126],"that":[127],"therapy":[129,191],"sensitivity":[130],"was":[134],"by":[136,150],"D2HG-mediated":[137],"downregulation":[138],"expression":[140],"response":[145],"gene":[146],"ATM":[147],"altered":[151],"redox":[152],"due":[154],"metabolic":[156],"alterations":[157],"Conclusions:":[161],"are":[165],"sensitive":[166],"as":[170,181],"monotherapy":[171],"but":[172],"especially":[173],"when":[174],"combined":[175],"DNA-damaging":[178],"agent,":[179],"such":[180],"whereas":[183],"concomitant":[184],"administration":[185],"during":[189],"cytotoxic":[190],"decrease":[192],"efficacy":[194],"both":[196],"agents":[197],"AML.":[200,221],"These":[201],"results":[202],"advocate":[203],"favor":[205],"clinical":[207],"trials":[208],"either":[212],"or":[213],"combination":[216],"Clin":[222],"Cancer":[223],"Res;":[224],"24(7);":[225],"1705\u201315.":[226],"\u00a92018":[227],"AACR.":[228]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-01-26T00:00:00"}